Ipilimumab treatment decreases circulating Tregs and GrMDSC while enhancing CD4+ T cell activation

Por Pico de Coaña, Yago, Wolodarski, Maria, Gentilcore, Giusy, Yoshimoto, Yuya, Poschke, Isabel, Hansson, Johan, Masucci, Giuseppe V, Kiessling, Rolf
Publicado no J Transl Med (2015)

Ipilimumab treatment enhances CD4+ T cell activation while decreasing Treg and MDSC frequency in advanced melanoma patients

Por Pico de Coaña, Yago, Poschke, Isabel, Yoshimoto, Yuya, Karlberg, Sara, Nyström, Maria, Wolodarski, Maria, Hansson, Johan, Masucci, Giuseppe, Kiessling, Rolf
Publicado no J Immunother Cancer (2014)

IL-15, TIM-3 and NK cells subsets predict responsiveness to anti-CTLA-4 treatment in melanoma patients

Por Tallerico, Rossana, Cristiani, Costanza M., Staaf, Elina, Garofalo, Cinzia, Sottile, Rosa, Capone, Mariaelena, Pico de Coaña, Yago, Madonna, Gabriele, Palella, Eleonora, Wolodarski, Maria, Carannante, Valentina, Mallardo, Domenico, Simeone, Ester, Grimaldi, Antonio M., Johansson, Sofia, Frumento, Paolo, Gulletta, Elio, Anichini, Andrea, Colucci, Francesco, Ciliberto, Gennaro, Kiessling, Rolf, Kärre, Klas, Ascierto, Paolo A., Carbone, Ennio
Publicado no Oncoimmunology (2016)